• Hologic, Inc. (NASDAQ:HOLX) displays a strong ROIC of 10.04%, indicating effective capital utilization compared to its peers.
• ResMed Inc. leads the group with a stunning ROIC of 20.06% and a ROIC to WACC ratio of 2.69.
• Companies like Henry Schein, Inc. and DENTSPLY SIRONA Inc. reveal lower capital efficiency, with ROIC to WACC ratios below 1.

Hologic, Inc. specializes in medical technology focusing on women’s health solutions. Competing in a vital sector, its financial performance is noteworthy.

Hologic’s ROIC is at 10.04%, while its WACC is 7.92%. The resulting ratio of 1.27 signifies a company effectively generating returns above its capital costs, showcasing efficiency.

In comparison, Henry Schein maintains a ROIC of 5.92%, falling below its WACC, suggesting investor concerns. DENTSPLY reflects a negative ROIC of -17.66%, a clear sign of inefficiency.

ResMed stands out with its significant ROIC compared to WACC, making it attractive for investors focused on capital returns. Overall, while Hologic is efficient, it trails ResMed in this regard.